Marvel Biosciences Corp at SNN Network Canada Virtual Event Transcript
Welcome to SNN Network Canada Virtual Event. I'd like to introduce our next presenter, Mark Williams of Marvell Biosciences, listed under TSX Venture under the symbol MRVL.
Sir, the floor is yours.
Thanks very much, and thank you to everyone participating this afternoon. This is our disclaimer, which you can read at your leisure and apologize for the slight delay.
So briefly speaking, Marvell is a biotechnology company focused on developing essentially known --derivatives of known drugs. We call this process drug redevelopment. And because of that, we believe as a company that we can significantly lower the cost, the time, and the risk associated with bringing a new chemical entity to the market, because we know the original toxicity, we know the target and, we know elements of the drug that allow us to do that very, very quickly.
Between us, we have, as management team, more than 50 years of experience. We have two compounds
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
